Professional business directory

Find the best businesses and services near you. Discover verified companies across all industries.

Category: systemic

systemic Oct 16

MODERN FINANCIAL ENGINEERING: COUNTERPARTY, CREDIT, PORTFOLIO AND SYSTEMIC RISKS - ORLANDO GIUSEPPE ET AL

AUTHOR AFFILIATION : UNIV OF BARI, ITALY PUB DATE : 28-Dec-21 ONLINE RELEASE DATE : 14-Jan-22

View Details
systemic Oct 16

SYSTEMIC RISK: HISTORY, MEASUREMENT AND REGULATION - KREIS YVONNE ET AL

AUTHOR AFFILIATION : JOHANNES GUTENBERG UNIV OF MAINZ, GERMANY PUB DATE : 4-Jun-19 ONLINE RELE

View Details
systemic Oct 16

SYSTEMIC IMPLICATIONS OF TRANSATLANTIC REGULATORY COOPERATION AND COMPETITION - STERN ROBERT M ET AL

AUTHOR AFFILIATION : UNIV OF MICHIGAN, USA PUB DATE : 16-Feb-11 ONLINE RELEASE DATE : 30-May-1

View Details
systemic Oct 16

SYSTEMIC HOMEOSTASIS AND POIKILOSTASIS IN SLEEP: IS REM SLEEP A PHYSIOLOGICAL PARADOX? - PARMEGGIANI PIER LUIGI

AUTHOR AFFILIATION : UNIV OF BOLOGNA, ITALY PUB DATE : 13-Dec-10 ONLINE RELEASE DATE : 14-Feb-

View Details
systemic Oct 16

GLOBALIZATION AND SYSTEMIC RISK - EVANOFF DOUGLAS ET AL

AUTHOR AFFILIATION : FEDERAL FESERVE BANK OF CHICAGO, USA PUB DATE : 5-Jan-09 ONLINE RELEASE D

View Details
systemic Oct 16

FIBROCYTES: NEW INSIGHTS INTO TISSUE REPAIR AND SYSTEMIC FIBROSES - BUCALA RICHARD

AUTHOR AFFILIATION : YALE UNIV, USA PUB DATE : 30-Jan-07 ONLINE RELEASE DATE : 4-Mar-09 Pri

View Details
systemic Oct 16

SYSTEMIC FINANCIAL CRISES: RESOLVING LARGE BANK INSOLVENCIES - EVANOFF DOUGLAS D ET AL

AUTHOR AFFILIATION : FEDERAL RESERVE BANK OF CHICAGO , USA PUB DATE : 27-Jun-05 ONLINE RELEASE

View Details
systemic Apr 01

Etablissement Université de Mostaganem - Abdelhamid Ibn Badis Affiliation Département d’Anglais Auteur Haddad, Nabil Directeur de thèse

Mémoires de Fin d’Etudes Etablissement Université de Mostaganem - Abdelhamid Ibn Badis Affiliation

View Details
systemic Sep 18

ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab)

ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen

View Details
systemic Sep 18

ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)

ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen

View Details
systemic Sep 18

ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)

ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen

View Details